African Swine Fever Virus pI215L Inhibits Type I Interferon Signaling by Targeting Interferon Regulatory Factor 9 for Autophagic Degradation.
African swine fever virus
IRF9
autophagy
pI215L
type I IFN signaling
Journal
Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724
Informations de publication
Date de publication:
14 09 2022
14 09 2022
Historique:
pubmed:
17
8
2022
medline:
17
9
2022
entrez:
16
8
2022
Statut:
ppublish
Résumé
African swine fever virus (ASFV) is the etiological agent of a highly lethal hemorrhagic disease in domestic pigs and wild boars that has significant economic consequences for the pig industry. The type I interferon (IFN) signaling pathway is a pivotal component of the innate antiviral response, and ASFV has evolved multiple mechanisms to antagonize this pathway and facilitate infection. Here, we reported a novel function of ASFV pI215L in inhibiting type I IFN signaling. Our results showed that ASFV pI215L inhibited IFN-stimulated response element (ISRE) promoter activity and subsequent transcription of IFN-stimulated genes (ISGs) by triggering interferon regulatory factor 9 (IRF9) degradation. Additionally, we found that catalytically inactive pI215L mutations retained the ability to block type I IFN signaling, indicating that this only known viral E2 ubiquitin-conjugating enzyme mediates IFR9 degradation in a ubiquitin-conjugating activity-independent manner. By coimmunoprecipitation, confocal immunofluorescence, and subcellular fractionation approaches, we demonstrated that pI215L interacted with IRF9 and impaired the formation and nuclear translocation of IFN-stimulated gene factor 3 (ISGF3). Moreover, further mechanism studies supported that pI215L induced IRF9 degradation through the autophagy-lysosome pathway in both pI215L-overexpressed and ASFV-infected cells. These findings reveal a new immune evasion strategy evolved by ASFV in which pI215L acts to degrade host IRF9 via the autophagic pathway, thus inhibiting the type I IFN signaling and counteracting the host innate immune response.
Identifiants
pubmed: 35972295
doi: 10.1128/jvi.00944-22
pmc: PMC9472647
doi:
Substances chimiques
Interferon Type I
0
Interferon-Stimulated Gene Factor 3, gamma Subunit
0
Ubiquitin-Conjugating Enzymes
EC 2.3.2.23
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0094422Références
J Gen Virol. 2018 May;99(5):613-614
pubmed: 29565243
J Virol. 2009 Mar;83(5):2099-108
pubmed: 19109393
Vaccines (Basel). 2020 Oct 03;8(4):
pubmed: 33023005
Annu Rev Biochem. 2012;81:203-29
pubmed: 22524316
Cell Microbiol. 2006 Jun;8(6):907-22
pubmed: 16681834
Virus Res. 2019 Sep;270:197667
pubmed: 31319112
Virology. 2016 Jun;493:154-61
pubmed: 27043071
Curr Opin Immunol. 2009 Feb;21(1):78-83
pubmed: 19203867
Virus Res. 2013 Apr;173(1):3-14
pubmed: 23142553
J Immunol. 2021 Dec 1;207(11):2754-2769
pubmed: 34759016
J Infect. 2019 Aug;79(2):174-187
pubmed: 31100363
J Immunol. 2020 Sep 1;205(5):1281-1292
pubmed: 32699158
J Gen Virol. 2008 Feb;89(Pt 2):397-408
pubmed: 18198370
mBio. 2022 Jan 25;:e0233021
pubmed: 35076286
Autophagy. 2021 Aug;17(8):1962-1977
pubmed: 32746697
FEBS Lett. 2000 Apr 7;471(1):17-22
pubmed: 10760505
Oncogene. 2013 Oct 17;32(42):5017-25
pubmed: 23178490
Virol Sin. 2022 Apr;37(2):157-167
pubmed: 35278697
J Virol. 2010 Mar;84(6):3079-93
pubmed: 20042513
J Virol. 2011 Dec;85(24):12890-900
pubmed: 21957283
Transbound Emerg Dis. 2022 Jul;69(4):e497-e504
pubmed: 34582622
EMBO J. 2013 Oct 16;32(20):2751-63
pubmed: 24065129
J Virol. 2013 Sep;87(17):9813-21
pubmed: 23824805
Cell. 2010 Mar 19;140(6):805-20
pubmed: 20303872
EMBO J. 1992 Jan;11(1):361-6
pubmed: 1310934
J Virol. 2017 Feb 28;91(6):
pubmed: 28031363
J Virol. 2015 Nov;89(22):11487-99
pubmed: 26339056
Antiviral Res. 2019 May;165:34-41
pubmed: 30836106
Emerg Microbes Infect. 2019;8(1):438-447
pubmed: 30898043
J Virol. 2001 Apr;75(7):3066-76
pubmed: 11238833
Vet J. 2018 Mar;233:41-48
pubmed: 29486878
Arch Virol. 2011 Apr;156(4):597-609
pubmed: 21203785
PLoS Pathog. 2012 Feb;8(2):e1002550
pubmed: 22383882
J Biol Chem. 1997 Aug 8;272(32):20070-6
pubmed: 9242679
J Virol. 2020 Apr 16;94(9):
pubmed: 32075923
Sci Rep. 2018 Feb 22;8(1):3471
pubmed: 29472632
Immunity. 2012 Apr 20;36(4):503-14
pubmed: 22520844
J Virol. 2019 Jul 17;93(15):
pubmed: 31092569
PLoS Pathog. 2015 May 14;11(5):e1004901
pubmed: 25973608
Front Vet Sci. 2020 May 13;7:215
pubmed: 32478103
Sci Rep. 2020 Oct 19;10(1):17605
pubmed: 33077775
Vaccines (Basel). 2017 Oct 07;5(4):
pubmed: 28991171
Virology. 2015 Nov;485:414-21
pubmed: 26342467
Annu Rev Anim Biosci. 2020 Feb 15;8:221-246
pubmed: 31743062
Front Microbiol. 2011 Jul 28;2:161
pubmed: 21847386
Viruses. 2011 Feb;3(2):118-31
pubmed: 22049306
J Virol. 2019 May 29;93(12):
pubmed: 30918080
Science. 1994 Jun 3;264(5164):1415-21
pubmed: 8197455
Immunity. 2019 Apr 16;50(4):907-923
pubmed: 30995506
Virus Res. 2019 Jun;266:25-33
pubmed: 30959069
Cell Host Microbe. 2009 Jun 18;5(6):559-70
pubmed: 19527883
Annu Rev Biochem. 2017 Jun 20;86:193-224
pubmed: 28460188
Virus Res. 2013 Apr;173(1):140-9
pubmed: 23376310
Virus Res. 2013 Apr;173(1):87-100
pubmed: 23165138
Nat Rev Immunol. 2005 May;5(5):375-86
pubmed: 15864272
Nat Cell Biol. 2009 May;11(5):527-34
pubmed: 19404332
J Immunol. 2006 Jan 1;176(1):451-62
pubmed: 16365438
Virology. 1996 Oct 1;224(1):25-33
pubmed: 8862396
J Immunol. 2021 Apr 15;206(8):1844-1857
pubmed: 33712518
Vaccines (Basel). 2020 Sep 15;8(3):
pubmed: 32942741
Viruses. 2021 Jun 17;13(6):
pubmed: 34204411
Virol Sin. 2021 Apr;36(2):176-186
pubmed: 33141406
Proc Natl Acad Sci U S A. 2022 May 10;119(19):e2201288119
pubmed: 35507870
Cytokine Growth Factor Rev. 2016 Jun;29:35-43
pubmed: 26987614
J Virol Methods. 1982 Jan;3(6):303-10
pubmed: 7085838
Viruses. 2017 May 10;9(5):
pubmed: 28489063
Nat Immunol. 2006 Feb;7(2):131-7
pubmed: 16424890
J Cell Biol. 2001 Feb 19;152(4):657-68
pubmed: 11266458
Nature. 2020 Jul;583(7816):459-468
pubmed: 32353859
Annu Rev Biochem. 1998;67:425-79
pubmed: 9759494
Mol Cell Biol. 1993 Jan;13(1):196-206
pubmed: 8417326
Front Microbiol. 2020 Dec 15;11:622907
pubmed: 33384682
J Virol. 2017 Feb 28;91(6):
pubmed: 28053104